Historical salary details - Dr. Roger J. Pomerantz, F.A.C.P.,M.D., Chairman of the Board, Indaptus Therapeutics Inc
Dr. Roger J. Pomerantz, F.A.C.P.,M.D. is the Chairman of the Board of Indaptus Therapeutics Inc. They also hold 2 other positions in Enlivex Therapeutics Ltd and CollPlant Biotechnologies Ltd - Ordinary Shares New.
Dr. Roger J. Pomerantz, F.A.C.P.,M.D.
Chairman of the Board
$ 216 K
Gross Remuneration
-
Current Company
Indaptus Therapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Indaptus Therapeutics Inc | Chairman of the Board | 216 K | 10.4 % |
| 2024 | Enlivex Therapeutics Ltd | Vice Chairman of the Board | - | - |
| 2024 | CollPlant Biotechnologies Ltd - Ordinary Shares New | Chairman of the Board | - | - |
| 2023 | Viracta Therapeutics Inc | Chairman of the Board | 210.3 K | -34.9 % |
| 2023 | Indaptus Therapeutics Inc | Chairman of the Board | 195.7 K | -33.5 % |
| 2023 | Enlivex Therapeutics Ltd | Vice Chairman of the Board | - | - |
| 2022 | Viracta Therapeutics Inc | Chairman of the Board | 322.8 K | -81.4 % |
| 2022 | Indaptus Therapeutics Inc | Chairman of the Board | 294.2 K | 27.0 % |
| 2022 | ContraFect Corp | Chairman of the Board, President and Chief Executi | - | - |
| 2022 | CollPlant Biotechnologies Ltd - Ordinary Shares New | Chairman of the Board | - | - |
| 2022 | Enlivex Therapeutics Ltd | Vice Chairman of the Board | - | - |
| 2021 | Viracta Therapeutics Inc | Chairman of the Board | 1.7 M | 618.0 % |
| 2021 | Indaptus Therapeutics Inc | Chairman of the Board | 231.7 K | - |
| 2021 | ContraFect Corp | Chairman of the Board, President and Chief Executi | - | - |
| 2021 | CollPlant Biotechnologies Ltd - Ordinary Shares New | Chairman of the Board | - | - |
| 2020 | Viracta Therapeutics Inc | Chairman of the Board | 241.2 K | - |
| 2020 | Indaptus Therapeutics Inc | Chairman of the Board | - | - |
| 2020 | CollPlant Biotechnologies Ltd - Ordinary Shares New | Chairman of the Board | - | - |
| 2020 | ContraFect Corp | Chairman of the Board, President and Chief Executi | - | - |
| 2019 | CollPlant Biotechnologies Ltd - Ordinary Shares New | Chairman of the Board | - | - |
| 2019 | Seres Therapeutics Inc | Chairman of the Board | - | - |
| 2019 | ContraFect Corp | Chairman of the Board, President and Chief Executi | - | - |
| 2018 | ContraFect Corp | Vice Chairman of the Board | 90.2 K | 1.1 % |
| 2018 | Seres Therapeutics Inc | Chairman of the Board | - | - |
| 2017 | ContraFect Corp | Vice Chairman of the Board | 89.3 K | -7.8 % |
| 2017 | Seres Therapeutics Inc | President, Chief Executive Officer and Chairman of | - | - |
| 2016 | ContraFect Corp | Vice Chairman of the Board | 96.8 K | -15.3 % |
| 2016 | Seres Therapeutics Inc | President, Chief Executive Officer and Chairman of | - | - |
| 2015 | ContraFect Corp | Vice Chairman of the Board | 114.4 K | -34.1 % |
| 2015 | Seres Therapeutics Inc | President, Chief Executive Officer and Chairman of | - | - |
| 2014 | ContraFect Corp | Vice Chairman of the Board | 173.7 K | - |
| 2014 | Seres Therapeutics Inc | President, Chief Executive Officer and Chairman of | - | - |
| 2013 | ContraFect Corp | Vice Chairman of the Board | - | - |